2,047 results on '"Giannarelli Diana"'
Search Results
102. Refinement & validation of rectal wall dose volume objectives for prostate hypofractionation in 20 fractions
103. Early Changes in LIPI Score Predict Immune-Related Adverse Events: A Propensity Score Matched Analysis in Advanced Non-Small Cell Lung Cancer Patients on Immune Checkpoint Blockade
104. Prognostic Impact of Interleukin-8 Levels in Lung Cancer: A Meta-Analysis and a Bioinformatic Validation
105. Epithelial ovarian cancer and brain metastases: might theBRCAstatus, PARP inhibitor administration, and surgical treatment impact the survival?
106. RETRACTED ARTICLE: Prognostic models for chronic lymphocytic leukemia (CLL): a systematic review and meta-analysis
107. Idiopathic acute pancreatitis: a single-center investigation of clinical and biochemical features
108. Low-gradeversushigh-grade serous ovarian cancer: comparison of surgical outcomes after secondary cytoreductive surgery
109. Efficacy and safety of chlorpromazine as an adjuvant therapy for glioblastoma in patients with unmethylated MGMT gene promoter: RACTAC, a phase II multicenter trial
110. Retrospective Correlation between First Drug Treatment Duration and Survival Outcomes in Sequential Treatment with Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer: A Real-World Subgroup Analysis
111. Liquid biopsy identifies actionable dynamic predictors of resistance to Trastuzumab Emtansine (T-DM1) in advanced HER2-positive breast cancer
112. Immunotherapy may protect cancer patients from SARS-CoV-2 infection: a single-center retrospective analysis
113. A monocentric phase I study of vemurafenib plus cobimetinib plus PEG-interferon (VEMUPLINT) in advanced melanoma patients harboring the V600BRAF mutation
114. Lower response to BNT162b2 vaccine in patients with myelofibrosis compared to polycythemia vera and essential thrombocythemia
115. Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution
116. Diabetes and diabetic retinopathy in patients undergoing cataract surgery: a prevalence study—DiCat study report #2
117. The impact of different FLT3-inhibitors on overall survival of de novo acute myeloid leukemia: A network meta-analysis
118. Epidemiology of Chronic Pain in the Latium Region, Italy: A Cross-Sectional Study on the Clinical Characteristics of Patients Attending Pain Clinics
119. State of the art about influenza vaccination for advanced cancer patients receiving immune checkpoint inhibitors: When common sense is not enough
120. Minimal Residual Disease and Survival Outcomes in Patients With Chronic Lymphocytic Leukemia: A Systematic Review and Meta-analysis
121. Robotic-assisted versus conventional laparoscopic surgery in the management of obese patients with early endometrial cancer in the sentinel lymph node era: a randomized controlled study (RObese).
122. Hormone replacement therapy in gynecological cancer survivors and BRCA mutation carriers: a MITO group survey.
123. Development of a Prognostic Model for Early Breast Cancer Integrating Neutrophil to Lymphocyte Ratio and Clinical-Pathological Characteristics.
124. Impact of targeted agents on survival of chronic lymphocytic leukemia patients age >65 relative to age‐ and sex‐matched population.
125. Validation of Esaso Classification of Diabetic Maculopathy.
126. Treatment Sequencing and Outcome of Chronic Lymphocytic Leukemia Patients Treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Thirty-Year Single-Center Experience
127. Immune responses and clinical outcomes following the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in advanced breast cancer patients receiving targeted therapies: a prospective study
128. TP022/#997 Sentinel-node biopsy in early stage ovarian cancer: preliminary results of a prospective multicentre study (SELLY)
129. CTNI-38. RACTAC TRIAL: PHASE II MULTICENTRIC ITALIAN TRIAL ON REPOSITIONING OF THE ANTIPSYCHOTIC DRUG CHLORPROMAZINE AND ITS COMBINATION WITH TEMOZOLOMIDE IN MGMT UNMETHYLATED GLIOBLASTOMA PATIENTS
130. SENTINEL-NODE BIOPSY IN APPARENT EARLY STAGE OVARIAN CANCER: FINAL RESULTS OF A PROSPECTIVE MULTICENTRE STUDY (SELLY)
131. #1119 Survival associated with extent of radical hysterectomy in early-stage cervical cancer: a sub-analysis of the SCCAN collaborative study
132. #759 Comprehensive cancer genomic profiling in matched primary tumor and brain metastasis samples of ovarian cancer patients: a single-institution case series
133. #226 Exploring the association between different mismatch repair deficient phenotypes and prognostic factors in endometrial cancer: a descriptive analysis
134. #826 Secondary cytoreductive surgery in endometrial cancer recurrence: a preoperative prediction model for complete gross resection
135. #881 The NUVOLA TRIAL: neoadjuvant chemoteraphy in unresectable ovarian cancer with olaparib and weekly carboplatin plus paclitaxel. A phase II open-label multi-centre study
136. #823 Comprehensive characterization of naïve treatment samples of high grade serous ovarian cancer addressed to neoadjuvant chemotherapy: a hypothesis-generating study on biomarkers of response to platinum-based chemotherapy
137. #119 Prediction of germline brca 1/2 genes pathogenetic variants from healthy ovaries ultrasound images: radiogenomics as an innovative tool to prevent BRCA-related cancers
138. Effects of Acetaminophen Exposure on Outcomes of Patients Receiving Immune Checkpoint Inhibitors for Advanced Non-Small-Cell Lung Cancer: A Propensity Score-Matched Analysis
139. #822 Expanding use of HIPEC at time of interval debulking surgery. a prospective analysis on perioperative and oncologic outcomes
140. T-DM1 and brain metastases: Clinical outcome in HER2-positive metastatic breast cancer
141. Use of nivolumab in elderly patients with advanced squamous non–small-cell lung cancer: results from the Italian cohort of an expanded access programme
142. Inflatable Penile Prosthesis Placement, Scratch Technique and Postoperative Vacuum Therapy as a Combined Approach to Definitive Treatment of Peyronie’s Disease
143. Tremelimumab combined with durvalumab in patients with mesothelioma (NIBIT-MESO-1): an open-label, non-randomised, phase 2 study
144. Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations
145. Prospective evaluation of metabolic syndrome and its features in a single-center series of hematopoietic stem cell transplantation recipients
146. Agnostic evaluation of ipilimumab and nivolumab association: a metanalysis
147. Blockage of interleukin-1β with canakinumab in patients with Covid-19
148. Corrigendum to “Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial” [Eur J Cancer 199 (2024) 113531]
149. An Innovative Scoring System to Select the Optimal Surgery in Breast Cancer after Neoadjuvant Chemotherapy
150. PB1933: TREATMENT SEQUENCING AND OUTCOME OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED AT FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS: A THIRTY-YEAR SINGLE-CENTER EXPERIENCE.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.